{"id":30884775,"date":"2025-01-23T07:35:20","date_gmt":"2025-01-23T06:35:20","guid":{"rendered":"https:\/\/www.upo.es\/diario\/?p=30884775"},"modified":"2025-01-23T16:35:55","modified_gmt":"2025-01-23T15:35:55","slug":"desarrollo-y-enfermedades-musculares","status":"publish","type":"post","link":"https:\/\/www.upo.es\/diario\/video\/2025\/01\/desarrollo-y-enfermedades-musculares\/","title":{"rendered":"Desarrollo y enfermedades musculares"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/Ef7ZoMG3Krg?si=BNr2M8n2ynVCVpCc\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Este grupo de investigaci\u00f3n de la Universidad Pablo de Olavide, que desarrolla su trabajo en el Centro Andaluz de Biolog\u00eda del Desarrollo, es<strong> referente internacional en la b\u00fasqueda de terapias frente a las enfermedades raras<\/strong>. As\u00ed, aplica el m\u00e9todo de trabajo basado en la medicina de precisi\u00f3n personalizada en el proyecto MITOCURE (centrado en las enfermedades mitocondriales), MYOCURE (centrado en las miopat\u00edas cong\u00e9nitas), BRAINCURE (centrado en la neurodegeneraci\u00f3n por acumulaci\u00f3n de hierro y las enfermedades desmielinizantes), y CANCERCURE (centrado en la b\u00fasqueda de tratamientos personalizados para la susceptibilidad gen\u00e9tica al c\u00e1ncer), ofreciendo nuevas v\u00edas terap\u00e9uticas a pacientes que hasta ahora solo contaban con tratamientos paliativos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Este grupo de investigaci\u00f3n de la Universidad Pablo de Olavide, que desarrolla su trabajo en el Centro Andaluz de Biolog\u00eda del Desarrollo, es referente internacional en la b\u00fasqueda de terapias frente a las enfermedades raras.<\/p>\n","protected":false},"author":6,"featured_media":30884776,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6038],"tags":[4996,43,6490,117,1832,6487],"class_list":["post-30884775","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-video","tag-biologia-celular","tag-cabd","tag-dia-de-la-universidad-pablo-de-olavide","tag-enfermedades-raras","tag-jose-antonio-sanchez-alcazar","tag-medicina-de-precision","post_format-post-format-video"],"_links":{"self":[{"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/posts\/30884775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/comments?post=30884775"}],"version-history":[{"count":3,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/posts\/30884775\/revisions"}],"predecessor-version":[{"id":30884807,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/posts\/30884775\/revisions\/30884807"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/media\/30884776"}],"wp:attachment":[{"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/media?parent=30884775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/categories?post=30884775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.upo.es\/diario\/wp-json\/wp\/v2\/tags?post=30884775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}